FreshLeaf works with a number of Australian and international medical cannabis companies. We also collaborate with key pharmacy partners to supplement our market intelligence data sets.
Our clients
FreshLeaf Analytics H2 2021
The H2 2021 report is FreshLeaf Analytics’ seventh market report on patients, products and pricing in the Australian medicinal cannabis market.
Key highlights include:
Market growth will exceed expectations in 2021 as active patient numbers surge towards 100,000
Revenue from product sales forecast at $230 million at year end
Product count continues to climb although the growth rate of new products is slowing
Average monthly spend continues its slow downward trend while average daily dose increases